Cinemark stock upgraded to ‘Buy’ by B.Riley, anticipating 2025 recovery By Investing.com

On Monday, B.Riley changed its rating on Cinemark Holdings (NYSE:) stock, lifting it from Neutral to Buy and significantly increasing the price target to $27.00, up from the previous $16.00. The upgrade comes after a reassessment of the company’s prospects despite earlier concerns about weak box office trends due to Hollywood strikes earlier in the year.

The firm’s analyst noted that while the exhibition industry as a whole has shown underwhelming performance throughout 2024, Cinemark’s shares have demonstrated resilience, with investors looking beyond current challenges towards a potential rebound in 2025. The analyst acknowledged that their initial expectations underestimated the company’s ability to overcome investor concerns.

The revised outlook for Cinemark is based on the anticipation of a stronger film slate in 2025, which is expected to drive a recovery in box office revenues. This positive sentiment has led to the decision to adjust the price target, reflecting a belief in the company’s growth potential over the next year.

The new price target of $27.00 is based on an unchanged target multiple that has been applied to the firm’s 2025 earnings estimates for Cinemark. This suggests a significant increase in value from the previous target, signaling increased confidence in the stock’s future performance.

Investors in Cinemark Holdings have seen the stock lag during much of 2024, but this upgrade indicates a shift in perspective from B.Riley, suggesting that the company could be poised for a turnaround as the market begins to focus on longer-term prospects.

In other recent news, Cinemark Holdings Inc. has reported strong earnings and revenue, with nearly $580 million in revenue and $70 million in adjusted EBITDA. The company managed to retire $150 million of COVID-related debt, demonstrating financial resilience. Titles like “Dune Part Two” and “Kung Fu Panda 4” attracted nearly 40 million viewers, despite a slight decline in the North American box office.

In the wake of these developments, Roth/MKM upgraded Cinemark Holdings stock from Neutral to Buy and raised the price target to $26. The firm’s analyst cited key drivers such as expected improvements in box office performance, debt reduction plans, and the potential reintroduction of capital returns to shareholders.

Moreover, strategic initiatives aimed at enhancing the movie-going experience and plans for capital expenditures of $150 million were mentioned by Cinemark’s management. Analysts from various firms noted the company’s strong market share performance in Q1 and its focus on alternative content, contributing to 14% of box office revenue. These recent developments provide an insight into Cinemark’s performance and future plans.

InvestingPro Insights

Following B.Riley’s upgrade of Cinemark Holdings (NYSE:CNK) to a Buy rating with a new price target of $27.00, recent data from InvestingPro provides additional context for investors considering the stock. The company’s market capitalization stands at $2.61 billion, with a forward-looking P/E ratio of 12.12, reflecting potential value at its current price. Notably, Cinemark has experienced a substantial 57.58% price increase over the last six months, aligning with the analyst’s recognition of the stock’s resilience.

InvestingPro Tips indicate that Cinemark’s stock price movements have been quite volatile, yet the company is trading near its 52-week high and has had a strong return over the last month, up by 29.35%. Additionally, analysts predict the company will be profitable this year, a factor that might have influenced B.Riley’s optimistic price target. With these considerations, investors can explore further insights and tips on Cinemark at https://www.investing.com/pro/CNK, including a total of 11 InvestingPro Tips available to guide investment decisions. To access these insights, use the coupon code PRONEWS24 for up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.